eli lilly gip glp-1 retatrutide #elililly #obesity #glp1 #diabetes #clinicaltrials #fda #pharma #drugdevelopment #healthcareinnovation The result of the late

GLP-1 agonists, such as liraglutide and semaglutide, are increasingly used in medical weight loss due to their ability to mimic the natural hormone glucagon-like peptide-1, which is, for the most part, responsible for regulating appetite and food intake

The most common problems are not mysterious

Compounded semaglutide may be a lower-cost alternative, but it is not FDA-approved, may differ in quality and effectiveness, and carries safety risks, so physician oversight and reliable pharmacy selection are critical before using these versions

Adequate nutrition and hydration are important for maintaining mental health, so managing these side effects effectively is essential